FDA NDC Directory · JSON-LD · Markdown

metyrosine

NDC 69238-1621 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAmneal Pharmaceuticals NY LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA213734
Dosage form / routeCAPSULE · ORAL
Active ingredientsMETYROSINE (250 mg/1)
Marketing started20200724
Package count2

External sources

Source: openFDA. Public-domain (CC0).